profit from every $100 of sales.
$0$100
Jackson Acquisition Company II
$0.06+0.00% today
-88.9% in 1 year
1-year low $0.061-year high $0.60
Trading close to its lowest price of the past year.
The essentials
Four questions every investor asks, answered in one line each.
more sales each year, on average.
0%20% a year
You pay $27.58 for every $1 of profit it makes in a year.
CheapExpensive
of earnings would pay off all its debt.
No debt5 years
Jackson Acquisition Company II vs. similar companies
How it compares with the largest companies in its industry.
| Company | Profit from $100 of sales | Sales growth a year | Price per $1 of profit |
|---|---|---|---|
| Jackson Acquisition Company II | 27.6× · No profit yet | ||
 Churchill Capital Corp X | No profit yet | ||
 Drugs Made In America Acquisition II | 155.8× · No profit yet | ||
 Bain Capital GSS Investment Cor | No profit yet | ||
 Cantor Equity Partners IV | 96.3× · No profit yet |
AI analysis
An AI analyst reads Jackson Acquisition Company II's last five years, its segments, earnings, insiders and peers, and writes the bull case, the bear case and what the price expects.
Run the AI analysisNo annual statements on file yet.
Valuation
- 27.6×
- –
- 0.16
- 1.0×
- 0.0×
- –
- –
- -10.6%
- 3.6%
- 0.0%
Profitability
- 0.0%
- 0.0%
- 0.0%
- 0.0%
- -0.2%
- 2.0%
- 3.7%
- 3.6%
- -0.2%
- –
Growth
- –
- +2,303.1%
- −41.2%
- –
- −22.3%
Financial health
- 0.4×
- 0.00
- 0.1%
- –
- 1.11
- 1.11
- 0.00
How it ranks in Financial Services
Each dot is where the company stands among every company over $300M in the sector. Further right is better.
Bottom 11%of 758
Bottom 7%of 605
Bottom 20%of 883
Bottom 12%of 927
News
Eric Jackson Says Tom Lee Is Right About Bitcoin Leading Stocks – But The Signal Is Too Noisy To Bet OnYahoo Finance · Sep 2, 2026Jackson Hole analyst roundup: Warsh's speech sends hike chances higher, may put Fed 'at odds' with TreasuryCNBC Markets · Aug 31, 202610 Terrifying Words From Fed Chair Kevin Warsh at Jackson Hole Have Spooked Wall StreetYahoo Finance · Aug 31, 2026U.S. stock futures slip as chances of rate hike rise after Warsh’s Jackson Hole commentsMarketWatch · Aug 31, 2026Gold plunges as Warsh’s Jackson Hole inflation concerns spark rate hike betsSeeking Alpha · Aug 28, 2026The newest story we have is from Sep 2, 2026.
Insider trades
Our insider feed has not updated since May 26, 2026. Trades filed after that are not listed yet.
No insider trades on file.
The seven classic investing rulebooks
2/7Passes 2 of 7. Each bar is how well the company fits that investor's published rules, from 0 to 100; 60 or more counts as a pass.
Warren Buffett
37No pass
Benjamin Graham
65Pass
Philip Fisher
38No pass
Peter Lynch
60Pass
Joel Greenblatt
8No pass
Charlie Munger
28No pass
Terry Smith
22No pass
Questions about Jackson Acquisition Company II
Is Jackson Acquisition Company II a good stock to buy?
A business with weak numbers that is not profitable yet. 2 of the 7 famous investors' published rulebooks we apply pass it. Whether it suits you depends on your goals and the price you pay; invest-like never tells anyone to buy or sell. The AI analysis lays out the case for and against. Read the Jackson Acquisition Company II AI analysis
What does Jackson Acquisition Company II do?
Jackson Acquisition Company II is a special purpose acquisition company (SPAC) led by a management team with experience in the healthcare and consumer sectors. It is in Shell Companies.
Does Jackson Acquisition Company II pay a dividend?
No. Jackson Acquisition Company II does not pay a dividend at the moment.
Is Jackson Acquisition Company II stock halal?
Questionable. Jackson Acquisition Company II sits in a grey zone: scholars disagree about its industry. How we check
Who are Jackson Acquisition Company II's competitors?
The largest listed companies in the same industry are Churchill Capital Corp X, Drugs Made In America Acquisition II, Bain Capital GSS Investment Cor and Cantor Equity Partners IV. The peers table on this page compares their profit, growth and price with Jackson Acquisition Company II's.
Prices: daily closes to Nov 13, 2026. Fundamentals: company reports via invest-like data.